相关实验视频
Updated: Feb 7, 2026

07:14
Acupuncture in a Rat Model of Asthma
Published on: August 25, 2020
6.6K
奥马利祖马布在喘-COPD重叠与喘中的比较有效性:一个回顾性队列研究
Hengxing Sun1,2, Yunlu Gu1,2, Yinghong Wang1,2
1Department of Respiratory and Critical Care Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Frontiers in medicine
|February 6, 2026
概括
在喘-COPD重叠 (ACO) 中的奥马利祖马布反应取决于Th2炎症,而不仅仅是ACO诊断. 评估Th2生物标志物可以为喘患者提供更好的生物疗法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘 - 慢性阻塞性肺病 (COPD) 重叠 (ACO) 呈现出诊断挑战和对奥马利祖马布等生物疗法的可变反应.
- 抗IgE疗法Omalizumab在ACO中表现出有限的疗效,这突显了了解治疗异质性的必要性.
- 这项研究调查了奥马利祖马布在ACO与非ACO喘中的疗效,以及诊断标准对生物标志物动态的影响.
研究的目的:
- 为了比较20周的奥马利祖马布在喘-COPD重叠 (ACO) 和非ACO喘患者中的疗效.
- 评估不同的ACO诊断标准如何影响Th2炎症生物标志物动态和临床结果.
- 在异质喘表型中确定奥马利祖马布反应的预测因子.
主要方法:
- 对接受奥马利祖马布治疗的喘患者的回顾性分析.
- 分类为ACO (ACO-A:之前的COPD诊断;ACO-B:BD后FEV1/FVC<0.7和吸烟史) 和非ACO组.
- 测量和对血清学,气道炎症 (FeNO,EOS) 和肺功能生物标志物 (FEV1,FVC) 的比较分析.
主要成果:
- 招募了74名患者:25名ACO-A,49名非ACO-A,11名ACO-B,63名非ACO-B. 这些患者中,有1名是ACO-A,有1名是ACO-B,有1名是ACO-B. 在ACO患者中,基线肺功能较差,吸烟暴露较高.
- 这两组都改善了喘控制测试 (ACT) 的得分. 非ACO-A显示FeNO和乙氨基酸 (EOS) 的显著下降,IgE和肺功能参数的增加.
- 与ACO-A组相比,非ACO-A组的IgE,FeNO和FEV1的变化更为明显.
结论:
- 高Th2的炎症内型,而不是ACO诊断标签,是对奥马利祖马布反应的关键预测因素.
- 对Th2炎症的直接评估优于ACO定义,用于指导生物治疗选择.
- 专注于炎症特征的个性化治疗策略可以改善复杂喘患者的治疗结果.
相关概念视频
Asthma-I: Introduction
3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification
4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K
Asthma-IV: Nursing Management
3.8K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.8K

